Dapsone-d4

CAT:
804-HY-B0688S1
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Dapsone-d4 - image 1

Dapsone-d4

  • Description:

    Dapsone-d4 is the deuterium labeled Dapsone. Dapsone (4,4′-Diaminodiphenyl sulfone) is an orally active and blood-brain penetrant sulfonamide antibiotic with bacteriostatic, antimycobacterial and antiprotozoal activities[1]. Dapsone?exerts effective antileprosy activity?and inhibits folate synthesis in cell extracts of?M. leprae. Dapsone is used for dermatologic disorder research, including leprosy, dermatitis herpetiformis, acne vulgaris et al[2][3].
  • Product Name Alternative:

    4,4′-Diaminodiphenyl sulfone-d4; DDS-d4
  • UNSPSC:

    12352005
  • Target:

    Antibiotic; Bacterial; Isotope-Labeled Compounds; Parasite; Reactive Oxygen Species (ROS)
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Others
  • Field of Research:

    Infection; Inflammation/Immunology
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=S(C1=C([2H])C([2H])=C(C([2H])=C1[2H])N)(C2=CC=C(C=C2)N)=O
  • Molecular Formula:

    C12H8D4N2O2S
  • Molecular Weight:

    252.33
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Y I Zhu, et al. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol|[3]Dapsone, Drug.com|[4]D Voeller, et al. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone) .J Infect Dis. 1994 Feb;169 (2) :456-9.|[5]Esther Moreno, et al. Evaluation of Skin Permeation and Retention of Topical Dapsone in Murine Cutaneous Leishmaniasis Lesions.Pharmaceutics. 2019 Nov 13;11 (11) :607.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Isotope-Labeled Compounds
  • Clinical Information:

    No Development Reported
  • CAS Number:

    1346602-12-7